Insulin glargine improves health related quality of life in patients with type 2 diabetes inadequately controlled on sulfonylurea plus metformin

被引：0

作者：

Vinik, AI

Dailey, G

Zhang, Q

机构：

[1] Inst Diabet Endocrinol & Metab Dis, Eastern Virginia Med Sch, Norfolk, VA USA

[2] Scripps Clin, La Jolla, CA USA

[3] Sanofi Aventis, Bridgewater, MA USA

来源：

DIABETOLOGIA | 2005年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

856

引用

页码：A312 / A312

页数：1

共 50 条

[21] Efficacy and safety of saxagliptin plus metformin versus acarbose plus metformin in type 2 diabetes patients inadequately controlled with metformin monotherapy
Du, J.
Liang, L.
Fang, H.
Xu, F.
Li, W.
Shen, L.
Mu, Y.
[J]. DIABETOLOGIA, 2016, 59 : S372 - S372
[22] Triple therapy in Type 2 diabetes: benefits of insulin glargine over rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
Rosenstock, J
Sugimoto, D
Strange, P
Stewart, J
Rak, ES
Dailey, G
[J]. DIABETOLOGIA, 2004, 47 : A57 - A57
[23] Patients with type 2 diabetes inadequately controlled on premixed insulin:: Effect of initiating insulin glargine plus oral agents on glycemic control in daily practice
Hammer, H
Schneider, K
Niemöller, E
[J]. DIABETES, 2005, 54 : A518 - A518
[24] Patients with type 2 diabetes inadequately controlled on premixed insulin: Effect of initiating insulin glargine plus oral agents on glycemic control in daily practice
Hammer, Harm
[J]. DIABETES, 2006, 55 : A115 - A115
[25] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
Pavlicek, V.
[J]. DIABETOLOGE, 2011, 7 (01): : 37 - 38
[26] THE COST-EFFECTIVENESS OF CANAGLIFLOZIN COMPARED WITH LIRAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN AND SULFONYLUREA IN FRANCE
Troelsgaard, A.
Pitcher, A.
Granados, D.
Hemels, M.
Lloyd, A.
[J]. VALUE IN HEALTH, 2014, 17 (07) : A346 - A347
[27] CHANGE IN QUALITY OF LIFE (EQ-5D) AMONG TYPE 2 DIABETES MELLITUS PATIENTS INADEQUATELY CONTROLLED WITH METFORMIN PLUS SULFONYLUREA AND TREATED WITH DAPAGLIFLOZIN AS TRIPLE THERAPY REGIMEN FOR 24 WEEKS
Sternhufvud, C.
Rohwedder, K.
Sugg, J.
Grandy, S.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A257 - A257
[28] Exenatide reduced body weight compared to insulin glargine in metformin and sulfonylurea-treated patients with type 2 diabetes
Brodows, R
Kim, D
Burger, J
Mihm, M
Johns, D
[J]. OBESITY RESEARCH, 2005, 13 : A132 - A132
[29] IDEGLIRA IMPROVES HEALTH UTILITY COMPARED WITH INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES
Freemantle, N.
Lingvay, I
Kongso, J. H.
Abrahamsen, T. J.
Bjorner, J. B.
[J]. VALUE IN HEALTH, 2015, 18 (07) : A614 - A614
[30] Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain
Riebenfeld, Daniela
Spirk, David
Mathis, Alexandra
Villiger, Lukas
Gerber, Philipp A.
Gasser, Urs Erwin
Lehmann, Roger
[J]. SWISS MEDICAL WEEKLY, 2015, 145

← 1 2 3 4 5 →